非HDL-C/HDL-C比率与美国成年人肉症之间的关联:基于人口的研究
Xin Li1, Xinyue Duan1, Jinjiang Li1
1First Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi Province, China.
Journal of health, population, and nutrition
|November 5, 2025
概括
非-HDL-C/HDL-C比率 (NHHR) 与美国人的肉症风险增加有关. 这种脂质生物标志物可能有助于管理和预测肉症,特别是在老龄化人口中.
科学领域:
- 心血管健康 心血管健康
- 老年学是一门学科.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 非HDL-C/HDL-C比率 (NHHR) 是一个反映脂蛋白平衡的关键脂质生物标志物.
- 有限的研究存在于NHHR对萨尔科佩尼亚的影响.
- 这项研究调查了NHHR和肉症风险之间的关联.
研究的目的:
- 检查血清NHHR水平与肉类的风险之间的相关性.
- 评估NHHR作为一种潜在的生物标志物,用于治疗和预测肉症.
主要方法:
- 利用了2011-2018年国家健康和营养检查调查 (NHANES) 的数据.
- 采用多变量逻辑回归来分析NHHR-sarcopenia关系.
- 进行了子组,灵敏度和受限立方支线分析,以确保稳定性和探索非线性.
主要成果:
- 包括5491名参与者;6.68%患有肉症.
- 升高的NHHR显示与肉症发病率有显著的正相关性 (OR=1.13).
- 最高的NHHR四分位数组比最低的NHHR四分位数组高出2.11倍.
结论:
- 在美国成年人群中,NHHR与肉类的风险增加有关.
- NHHR可以作为一种有价值的生物标志物来评估肉症风险.
- 进一步的研究可以探索NHHR在临床肉症管理策略中的作用.
相关概念视频
Hazard Ratio
554
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
554
Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Coronary Artery Disease I: Introduction
863
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
863
Atherosclerosis III: Management
307
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Cardiomyopathy III: Hypertrophic Cardiomyopathy
380
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
221
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
221


